[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.184.210. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Special Article
Feb 11, 2013

When Choosing Statin TherapyThe Case for Generics

JAMA Intern Med. 2013;173(3):229-232. doi:10.1001/jamainternmed.2013.1529
Abstract

The development of “Top 5” lists across specialties and at regular intervals can help to remind physicians that optimal care is often possible at a lower cost. For purposes of cardiovascular risk reduction, generic statins, or their brand equivalents if priced similarly, remain the appropriate choice for dyslipidemic patients initiating statin therapy. In this article, we review the evidence supporting the choice of generic statins.

×